EpiCast Report: Clostridium Difficile Infection (CDI) Epidemiology Forecast to 2024 Now Available at

iData Insights
EpiCast Report: Clostridium Difficile Infection (CDI) - Epidemiology Forecast to 2024 Summary Clostridium difficile
infections (CDI) are primarily transmitted through the fecal-oral route. There are two major sources of CDI:
healthcare-associated CDI (HA-CDI) and community-associated CDI (CA-CDI). The typical clinical symptoms of CDI
range from watery diarrhea, anorexia, and nausea, to hypoalbuminemia and abdominal tenderness in severe cases.
Though suspected in all patients with antibiotic-associated diarrhea, the confirmatory diagnosis of CDI is primarily
based on the combination of clinical features exhibited by the patient and the results of various laboratory tests
including stool tests, as well as, in certain rare scenarios, endoscopy or radiologic tests. Recurrence and
complications of CDI usually pose grave challenges for the treatment and management of this condition and occur in
about 20-30% of the patients treated successfully for their first episode. GlobalData epidemiologists predict that the
diagnosed incident cases of all-CDI will grow from 686,540 cases in 2014 to 825,021 cases in 2024, at an Annual
Growth Rate (AGR) of 2.02% over the 10-year forecast period. Throughout the forecast period, the US will have the
highest number of diagnosed incident cases of all-CDI in the 7MM. This report provides an overview of the risk
factors, comorbidities, and the global and historical trends for CDI in the seven major markets (7MM) (US, France,
Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident
cases of all-CDI segmented by sex and by age (in five-year age groups beginning at 18 years and ending at =85
years). The term all-CDI is defined as any instance of suspected CDI and diarrhea, with stool samples testing positive
for toxin A, B, or both (enzyme immunoassay [EIA], cytotoxicity test, or polymerase chain reaction [PCR]) or revealing
the presence of toxin-producing C. difficile, and includes both HA-CDI and CA-CDI. The report also provides the 10year epidemiology forecast for the all-CDI cases segmented by epidemiological association into HA-CDI and CA-CDI.
Additionally, the report provides a 10-year epidemiological forecast for the recurrent all-CDI cases with a further
segmentation by number of recurrences. Scope - The Clostridium difficile infection (CDI) EpiCast Report provides an
overview of the risk factors, comorbidities, and global trends for CDI in the seven major markets (7MM) (US, France,
Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident
cases of all-CDI segmented by sex and by age (in five-year age groups beginning at 18 years and ending at =85
years). - The CDI epidemiology report is written and developed by Masters- and PhD-level epidemiologists. - The
EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in
the 7MM. Reasons to buy The Clostridium Difficile Infection (CDI) EpiCast series will allow you to - - Develop
business strategies by understanding the trends shaping and driving the global CDI market. - Quantify patient
populations in the global CDI market to improve product design, pricing, and launch plans. - Organize sales and
marketing efforts by identifying the sex and age groups that present the best opportunities for CDI therapeutics in
each of the markets covered.
Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landing-page.php?id=124182/epicastreport-clostridium-difficile-infection-cdi-epidemiology-forecast-to-2024
To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landing-page.php?id=124182/epicastreport-clostridium-difficile-infection-cdi-epidemiology-forecast-to-2024
Table of Contents
1 Table of Contents
4 1.1 List of Tables
6 1.2 List of Figures
7 2 Introduction
8 2.1 Catalyst
8 2.2 Related Reports
9 2.3 Upcoming Reports
9 3 Epidemiology

10 3.1 Disease Background

10 3.2 Risk Factors and Comorbidities
11 3.3 Global Trends
13 3.3.1 7MM: Diagnosed Incidence Rates
15 3.3.2 7MM: Diagnosed Incident Cases by Epidemiological Association
16 3.3.3 7MM: Diagnosed Incident Cases by Recurrences
16 3.4 Forecast Methodology
17 3.4.1 Sources Used
19 3.4.2 Sources Not Used
25 3.4.3 Forecast Assumptions and Methods
28 3.5 Epidemiological Forecast of CDI (2014-2024)
34 3.5.1 Diagnosed Incident Cases of All-CDI
34 3.5.2 Age-Specific Diagnosed Incident Cases of All-CDI
36 3.5.3 Sex-Specific Diagnosed Incident Cases of All-CDI
38 3.5.4 Age-Standardized Diagnosed Incidence Rate of All-CDI
40 3.5.5 Recurrent CDI Cases
42 3.5.6 Diagnosed Incident Cases of All-CDI by Epidemiological Association
43 3.6 Discussion
45 3.6.1 Epidemiological Forecast Insight
45 3.6.2 Limitations of the Analysis
47 3.6.3 Strengths of the Analysis
47 4 Appendix 48 4.1 Bibliography
48 4.2 About the Authors
55 4.2.1 Epidemiologists
55 4.2.2 Reviewers
55 4.2.3 Global Director of Therapy Analysis and Epidemiology
57 4.2.4 Global Head of Healthcare
57 4.3 About GlobalData
58 4.4 About EpiCast
58 4.5 Disclaimer
Read More @ http://www.idatainsights.com/reports-landing-page.php?id=124182/epicast-report-clostridium-difficileinfection-cdi-epidemiology-forecast-to-2024
About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research
information aggregator and marketing research consulting firm. We conduct both primary and secondary research.
Our work does not end with research it is also involved in distributing reports for different companies . We provide
actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be
a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that
will make a difference to their bottom line.

Contact Us:
iData Insights
Tel: 1-866-237-2965
Web: http://www.idatainsights.com
Email: info@idatainsights.com

About iData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to
provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our
promise to provide results that are essential to the success of your company. We believe that by doing so, we will
earn the trust of our clients for future projects.